Tadalafil Tablet, Film Coated
Product Images NDC 51655-473

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 51655-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 473 54)

Label for Tadalafil tablets, USP 20 mg, film-coated oral tablets. The box contains 15 tablets and is labeled for prescription use only. The label includes storage instructions and states tablets should not be split. The product is labeled by Northwind Health Company, LLC with NDC 51655-473-54.*

FDA Label Image

Figure (Tadalafil Figure1)

Four line graphs depicting blood pressure changes over time, labeled Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP, and Supine Diastolic BP. Each graph shows the difference between Tadalafil 20 mg and placebo in mmHg on the y-axis and time in hours on the x-axis, ranging from 0 to 96 hours, with error bars indicating variability.*

FDA Label Image

Figure (Tadalafil Figure2)

Two line graphs depicting standing and supine systolic blood pressure changes over 24 hours post-dose. The upper graph shows standing systolic BP with curves for Tadalafil 20 mg & doxazosin 8 mg and placebo & doxazosin 8 mg. The lower graph shows supine systolic BP changes for the same treatments over time.*

FDA Label Image

Figure (Tadalafil Figure3)

A line graph showing the effect on systolic blood pressure (mmHg) over 12 hours after administration of tadalafil 20 mg or placebo, both combined with 8 mg doxazosin. Four lines represent data for drug or placebo given at 08:00 or 20:00, illustrating changes in systolic BP over time.*

FDA Label Image

Figure (Tadalafil Figure4)

A line graph showing plasma tadalafil concentration (µg/L) over time (hours) for three dosing regimens: single 20-mg dose, single 5-mg dose, and once-daily 5-mg dose following 5 consecutive days of administration. The graph includes data points with error bars representing variability for each regimen across a 0 to 120 hour timeframe.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

A line graph comparing the change from baseline in IPSS total score over 12 weeks of treatment between tadalafil 5 mg and placebo. The x-axis shows treatment duration in weeks (0, 4, 8, 12), and the y-axis shows the change in score, with tadalafil demonstrating a greater reduction than placebo. Statistical significance is noted at p<0.01.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

A line graph comparing change from baseline in IPSS total score over a 12-week treatment duration between tadalafil 5 mg and placebo groups. The x-axis represents weeks of treatment (0, 1, 4, 8, 12), and the y-axis shows change in IPSS score, with tadalafil showing a greater reduction than placebo over time. Statistical significance is noted at p<0.01.*

FDA Label Image

Figure 7 (Tadalafil Figure7)

A line graph showing least-squares mean change from baseline over weeks of therapy (0, 4, 12, 26) comparing Tadalafil/Finasteride and Placebo/Finasteride groups. The graph depicts treatment differences at each time point, with Tadalafil/Finasteride showing greater reductions from baseline.*

FDA Label Image

Figure 8 (Tadalafil Figure8)

Line graph showing change from baseline in IPSS Total Score over a 12-week duration of treatment comparing tadalafil 5 mg and placebo. The graph depicts greater reductions in score with tadalafil treatment across the time points measured, with statistical significance noted.*

FDA Label Image

Chemical Structure (Tadalafil Structure)

Chemical structure diagram of tadalafil, showing its molecular framework with labeled bonds and rings as part of the active ingredient representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.